Published in Curr Mol Med on May 01, 2012
Structure of the mitochondrial translocator protein in complex with a diagnostic ligand. Science (2014) 1.29
Molecular imaging of microglial activation in amyotrophic lateral sclerosis. PLoS One (2012) 1.07
Linking Activation of Microglia and Peripheral Monocytic Cells to the Pathophysiology of Psychiatric Disorders. Front Cell Neurosci (2016) 0.84
Imaging of carrageenan-induced local inflammation and adjuvant-induced systemic arthritis with [(11)C]PBR28 PET. Nucl Med Biol (2013) 0.82
Translocator protein-mediated pharmacology of cholesterol transport and steroidogenesis. Mol Cell Endocrinol (2015) 0.82
Possible immunosuppressive effects of drug exposure and environmental and nutritional effects on infection and vaccination. Mediators Inflamm (2015) 0.81
Obesity-induced down-regulation of the mitochondrial translocator protein (TSPO) impairs placental steroid production. J Clin Endocrinol Metab (2015) 0.81
Functional gains in energy and cell metabolism after TSPO gene insertion. Cell Cycle (2017) 0.80
Tetrapyrroles as Endogenous TSPO Ligands in Eukaryotes and Prokaryotes: Comparisons with Synthetic Ligands. Int J Mol Sci (2016) 0.77
Quinazoline-based tricyclic compounds that regulate programmed cell death, induce neuronal differentiation, and are curative in animal models for excitotoxicity and hereditary brain disease. Cell Death Discov (2015) 0.76
Prognostic role of translocator protein and oxidative stress markers in chronic lymphocytic leukemia patients treated with bendamustine plus rituximab. Oncol Lett (2014) 0.75
Memory and hippocampal architecture following short-term midazolam in western diet-treated rats. Neurosci Lett (2016) 0.75
The impact of high and low dose ionising radiation on the central nervous system. Redox Biol (2016) 0.75
Classical and Novel TSPO Ligands for the Mitochondrial TSPO Can Modulate Nuclear Gene Expression: Implications for Mitochondrial Retrograde Signaling. Int J Mol Sci (2017) 0.75
Effect of the CRAC Peptide, VLNYYVW, on mPTP Opening in Rat Brain and Liver Mitochondria. Int J Mol Sci (2016) 0.75
Ligands specific to peripheral benzodiazepine receptors for treatment of porphyrias. Lancet (1989) 1.38
Salivary analysis of oral cancer biomarkers. Br J Cancer (2009) 1.29
Guanine nucleotide and cation regulation of the binding of [3H]cyclohexyladenosine and [3H]diethylphenylxanthine to adenosine A1 receptors in brain membranes. Mol Pharmacol (1982) 1.12
Specific ligands of the peripheral benzodiazepine receptor induce apoptosis and cell cycle arrest in human colorectal cancer cells. Br J Cancer (2001) 1.07
Increased density of peripheral benzodiazepine-binding sites in ovarian carcinomas as compared with benign ovarian tumours and normal ovaries. Clin Sci (Lond) (1990) 0.98
Peripheral-type benzodiazepine receptors in the regulation of proliferation of MCF-7 human breast carcinoma cell line. Biochem Pharmacol (1999) 0.95
Expression of functional P2-purinergic receptors in primary cultures of human colorectal carcinoma cells. Biochem Biophys Res Commun (1998) 0.94
Solubilized adenosine receptors in the brain: regulation of guanine nucleotides. Science (1982) 0.91
Folding and interaction of subunits at the antibody combining site. Biochemistry (1976) 0.91
The 18 kDa mitochondrial translocator protein (TSPO) prevents accumulation of protoporphyrin IX. Involvement of reactive oxygen species (ROS). Curr Mol Med (2012) 0.90
Solubilization of histamine H-1, GABA and benzodiazepine receptors. Life Sci (1979) 0.89
Transcription of actin, cyclophilin and glyceraldehyde phosphate dehydrogenase genes: tissue- and treatment-specificity. Biochim Biophys Acta (1999) 0.88
PK 11195 attenuates kainic acid-induced seizures and alterations in peripheral-type benzodiazepine receptor (PBR) protein components in the rat brain. J Neurochem (2002) 0.88
Increase in peripheral benzodiazepine binding sites in colonic adenocarcinoma. Oncology (1990) 0.88
Decreased platelet peripheral-type benzodiazepine receptors in adolescent inpatients with repeated suicide attempts. Biol Psychiatry (1999) 0.88
Binding of [3H]Ro 5-4864 and [3H]PK 11195 to cerebral cortex and peripheral tissues of various species: species differences and heterogeneity in peripheral benzodiazepine binding sites. J Neurochem (1987) 0.88
Peripheral benzodiazepine binding sites on platelet membranes are increased during diazepam treatment of anxious patients. Eur J Pharmacol (1987) 0.87
Hormonal regulation of peripheral benzodiazepine receptor binding properties is mediated by subunit interaction. Biochemistry (2001) 0.87
Decreased peripheral benzodiazepine binding sites in platelets of neuroleptic-treated schizophrenics. Eur J Pharmacol (1986) 0.86
Cigarette smoke decreases salivary 18 kDa translocator protein binding affinity--in association with oxidative stress. Curr Med Chem (2010) 0.85
Ice nucleation by alcohols arranged in monolayers at the surface of water drops. Science (1990) 0.85
Solubilization of muscarinic acetylcholine receptor by zwitterionic detergent from rat brain cortex. Biochem Biophys Res Commun (1982) 0.84
Dramatic increase in peripheral benzodiazepine binding sites in human colonic adenocarcinoma as compared to normal colon. Eur J Pharmacol (1988) 0.83
Induction of prolactin (PRL) receptors by PRL in the rat lung and liver. Demonstration and characterization of a soluble receptor. Endocrinology (1984) 0.83
Antiproliferative and differentiating effects of benzodiazepine receptor ligands on B16 melanoma cells. Biochem Pharmacol (1998) 0.83
Pleural fluid analysis of lung cancer vs benign inflammatory disease patients. Br J Cancer (2010) 0.83
Immunomodulatory effect of peripheral benzodiazepine receptor ligands on human mononuclear cells. J Neuroimmunol (1992) 0.83
Neural and behavioral alterations after early exposure to phenobarbital. Neurotoxicology (1989) 0.83
Benzodiazepine recognition sites on GABA receptors. Nature (1980) 0.82
gamma-Aminobutyric acid and benzodiazepine receptors: copurification and characterization. Proc Natl Acad Sci U S A (1981) 0.82
Effects of peripheral-type benzodiazepine receptor antisense knockout on MA-10 Leydig cell proliferation and steroidogenesis. J Biol Chem (1998) 0.82
Preparation of a semisynthetic antibody. Biochemistry (1978) 0.81
Preparation and characterization of antibodies to the lambda chain variable region (Vlambda) of mouse immunoglobulins. Eur J Immunol (1978) 0.81
Modulatory action of benzodiazepines on human term placental steroidogenesis in vitro. Mol Cell Endocrinol (1989) 0.81
Platelet benzodiazepine binding in Alzheimer's disease. Biol Psychiatry (1990) 0.81
The effect of oxygenation level on cerebral post-traumatic apoptotsis is modulated by the 18-kDa translocator protein (also known as peripheral-type benzodiazepine receptor) in a rat model of cortical contusion. Neuropathol Appl Neurobiol (2007) 0.80
Soluble benzodiazepine receptors: GABAergic regulation. Life Sci (1980) 0.80
Species differences and heterogeneity of solubilized peripheral-type benzodiazepine binding sites. Biochem Pharmacol (1989) 0.80
Ro 5-4864 and PK 11195, but not diazepam, depress cardiac function in an isolated working rat heart model. Pharmacology (1993) 0.80
Acute and repeated swim stress effects on peripheral benzodiazepine receptors in the rat hippocampus, adrenal, and kidney. Neuropsychopharmacology (2001) 0.79
Comparison of the fine specificity of anti-dinitrophenyl-combining site composed of either VL dimer or VL and VH of protein 315. Biochemistry (1977) 0.79
Peripheral-type benzodiazepine receptors in human cerebral cortex, kidney, and colon. Life Sci (1991) 0.79
Platelet peripheral benzodiazepine receptors in repeated stress. Life Sci (1991) 0.79
Prenatal stress impairs maternal behavior in a conflict situation and reduces hippocampal benzodiazepine receptors. Life Sci (1985) 0.79
Molecular cellular and behavioral aspects of peripheral-type benzodiazepine receptors. Clin Neuropharmacol (1993) 0.78
Solubilization of peripheral benzodiazepine-binding sites from rat kidney. J Neurosci (1985) 0.78
Characterization of CHAPS-solubilized prolactin receptors induced by estradiol in liver of male rats. Unmasking of cryptic sites by CHAPS. FEBS Lett (1983) 0.78
Interactions between laudanosine, GABA, and opioid subtype receptors: implication for laudanosine seizure activity. Brain Res (1994) 0.78
Antiidiotypic antibodies raised against anti-prolactin (PRL) antibodies recognize the PRL receptor. Endocrinology (1986) 0.78
Identification and distribution of peripheral benzodiazepine binding sites in male rat genital tract. Biochem Pharmacol (1990) 0.78
Changes in the density of peripheral benzodiazepine binding sites in genital organs of the female rat during the oestrous cycle. J Reprod Fertil (1988) 0.78
The effect of freezing and thawing or of detergent treatment on peripheral benzodiazepine binding: the possible existence of an endogenous ligand. Eur J Pharmacol (1985) 0.78
Chronic ethanol consumption and withdrawal affects mitochondrial benzodiazepine receptors in rat brain and peripheral organs. Biochem Pharmacol (1992) 0.78
PK 11195 aggravates 3,5-diethoxycarbonyl-1,4-dihydrocollidine-induced hepatic porphyria in rats. Hepatology (1996) 0.78
Platelet peripheral-type benzodiazepine receptor in major depression. J Affect Disord (1995) 0.78
Hippocampal gamma-aminobutyric acid and benzodiazepine receptors after early phenobarbital exposure. Brain Res Dev Brain Res (1993) 0.77
Modulatory effects of thyroxine treatment on central and peripheral benzodiazepine receptors in the rat. J Neurochem (1986) 0.77
Modulation of peripheral benzodiazepine receptors in female rat genital organs by various gonadal steroids. Life Sci (1994) 0.77
Carbamazepine up-regulates the binding of [3H]PK 11195 to platelets of epileptic patients. Eur J Pharmacol (1987) 0.77
Interactions of chloroquine with benzodiazepine, gamma-aminobutyric acid and opiate receptors. Biochem Pharmacol (1991) 0.77
Examination stress, platelet peripheral benzodiazepine binding sites, and plasma hormone levels. Life Sci (1989) 0.77
Increase in central and peripheral benzodiazepine receptors following surgery. Brain Res (1988) 0.77
Tissue-specific regulation of the peripheral benzodiazepine receptor by antidepressants and lithium. Neuropsychobiology (2000) 0.77
Ontogenesis of peripheral benzodiazepine receptors: demonstration of selective up-regulation in rat testis as a function of maturation. J Recept Res (1992) 0.76
Modulation of peripheral benzodiazepine binding sites following chronic estradiol treatment. Eur J Pharmacol (1986) 0.76
Peripheral-type benzodiazepine receptor ligands and serum steroid hormones. Brain Res (1997) 0.76
Ovarian steroids and stress produce changes in peripheral benzodiazepine receptor density. Eur J Pharmacol (1998) 0.76
Gonadotropin- and estrogen-induced increase of peripheral-type benzodiazepine binding sites in the hypophyseal-genital axis of rats. Eur J Pharmacol (1987) 0.76
Effect of hypophysectomy and hormone treatment on the induction of peripheral-type benzodiazepine binding sites in female rat genital axis. Horm Metab Res (1989) 0.76
Long-term testosterone or diethylstilbestrol treatment affects gamma-aminobutyric acid and central-type benzodiazepine receptors but not peripheral-type benzodiazepine receptors in the female rat brain. Neuroendocrinology (1993) 0.76
Chronic phenobarbital administration affects GABA and benzodiazepine receptors in the brain and periphery. Eur J Pharmacol (1989) 0.76
Absence of peripheral-type benzodiazepine binding sites in renal carcinoma: a potential biochemical marker. Br J Urol (1989) 0.76
Characterization of peripheral benzodiazepine binding sites in human term placenta. Biochem Pharmacol (1986) 0.76
Peripheral-type benzodiazepine receptor ligands modulate human natural killer cell activity. Int J Immunopharmacol (1997) 0.76
Impact of pregnancy and lactation on GABA(A) receptor and central-type and peripheral-type benzodiazepine receptors. Brain Res (1997) 0.76
Food deprivation modulates gamma-aminobutyric acid receptors and peripheral benzodiazepine binding sites in rats. Brain Res (1990) 0.76
Significant inhibition of spontaneous IgA secretion by selective peripheral-type benzodiazepine receptor ligands. Clin Neuropharmacol (1997) 0.76
Long-lasting effect of early handling on the peripheral benzodiazepine receptor. Pharmacol Biochem Behav (1999) 0.76
Disulfiram and diethyldithiocarbamate are competitive inhibitors at the peripheral benzodiazepine receptor. J Pharmacol Exp Ther (1992) 0.76
Regulation of central and peripheral benzodiazepine receptors in progesterone-treated rats. Brain Res (1987) 0.75
Aminophylline reversal of diazepam intoxication. Lancet (1989) 0.75
"Peripheral" benzodiazepine receptor density is not altered by methylphenidate treatment in children with attention-deficit hyperactivity disorder. J Child Adolesc Psychopharmacol (1993) 0.75
On the role of Tyr 34L in the antibody combining site of the dinitrophenyl binding protein 315. Mol Immunol (1979) 0.75
Effects of chronic prenatal, neonatal and adult exposure to barbiturates on mitochondrial benzodiazepine receptors in mouse testis. Biochem Pharmacol (1994) 0.75
Alteration of platelet benzodiazepine receptors by stress of war. Am J Psychiatry (1994) 0.75
Anti-V region framework antibodies affect the ligand binding of VL dimer. Eur J Immunol (1979) 0.75
Laudanosine does not displace receptor-specific ligands from the benzodiazepinergic or muscarinic receptors. Anesthesiology (1989) 0.75
Reciprocal effects of chronic diazepam and melatonin on brain melatonin and benzodiazepine binding sites. J Pineal Res (1996) 0.75
Ro 5-4864 has a negative inotropic effect on human atrial muscle strips that is not antagonized by PK 11195. Eur J Pharmacol (1994) 0.75
Protection of soluble benzodiazepine receptors from heat inactivation by GABAergic ligands. Life Sci (1983) 0.75
Down-regulation of hepatic peripheral-type benzodiazepine receptors caused by acute lead intoxication. Eur J Pharmacol (1995) 0.75
Antibody specificity: a 270-MHz hydrogen-1 nuclear magnetic resonance study of the binding of dinitrophenyl compounds to the VL dimer of protein 315. Biochemistry (1981) 0.75
Differential effect of detergents on [3H]Ro 5-4864 and [3H]PK 11195 binding to peripheral-type benzodiazepine-binding sites. Life Sci (1988) 0.75
Solubilization of peripheral-type benzodiazepine binding sites from cat cerebral cortex. J Neurochem (1989) 0.75
Effect of the neuroactive steroid alpha-THDOC on staircase test behavior in mice. Psychopharmacology (Berl) (1996) 0.75
Effect of the pregnane-related GABA-active steroid alphaxalone on mice performance in the staircase test. Brain Res (1997) 0.75
Repeated swim stress and peripheral-type benzodiazepine receptors. Neuropsychobiology (1996) 0.75
Modulatory effect of antidepressants on peripheral-type benzodiazepine receptors. Eur J Pharmacol (1993) 0.75
Electroconvulsive therapy down-regulates platelet peripheral-type benzodiazepine receptors in medication-resistant major depressed patients. Biol Psychiatry (1996) 0.75
Hormonal regulation of peripheral benzodiazepine binding sites in female rat adrenal gland and kidney. J Recept Res (1989) 0.75